Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
AU565
HER2amp
Luminal
Fascaplysin
CDK4
CDK
5900.085
uM
0.22253
0.56950
-0.7376 -0.7889 1.0076 0.5715
0.9983
2.6391
MCF12A
NM
Basal B
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7490.067
uM
7.63710
11.76840
-0.7152 -0.7251 2.0726 0.3536
0.9981
2.6472
MCF12A
NM
Basal B
Ispinesib
KSP
Kinesin
7490.067
uM
0.14468
2.57510
-0.6794 -1.0000 0.3816 0.4977
0.8901
2.6472
MCF12A
NM
Basal B
Purvalanol A
CDK1
CDK
7490.067
uM
inf
inf
0.9463 0.9463 0.0000 0.0115
0.2333
2.6472
Hs 578T
TNBC
Basal B
GSK1838705A
IGF1R
RTK
7474.071
uM
38.7770
28.5060
0.3928 0.3924 4.9912 0.0331
0.9633
2.6483
MCF 10A
NM
Basal B
Cetuximab
EGFR
ErbB
9551.026
uM
inf
0.14350
0.7282 0.7281 4.9914 0.0090
0.9280
2.6508
MCF 10A
NM
Basal B
CGC-11047
Polyamine analogue
9551.026
uM
185.91980
1000.00000
-0.6377 -0.8853 0.6057 0.3813
0.7752
2.6508
MCF 10A
NM
Basal B
Trastuzumab
HER2
ErbB
9551.026
uM
inf
inf
0.9124 0.9124 0.0000 -0.0111
0.4645
2.6508
MCF 10A
NM
Basal B
GSK1838705A
IGF1R
RTK
7484.09
uM
inf
0.39993
0.5550 0.5919 1.0858 0.1983
0.9279
2.6525
MCF 10A
NM
Basal B
Imatinib
ABL/KIT/PDGFR
nRTK
7484.09
uM
27.63420
39.63650
-0.7365 -0.7394 2.5167 0.3858
0.9956
2.6525
MCF 10A
NM
Basal B
Erlotinib
EGFR
ErbB
7484.09
uM
1.93170
3.34270
-0.0487 -0.2143 0.6504 0.3081
0.9911
2.6525
MCF 10A
NM
Basal B
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7484.094
uM
inf
0.87271
0.6437 0.6466 1.6780 0.2352
0.8160
2.6561
MCF 10A
NM
Basal B
Ixabepilone
TUBB
TUBB
7484.094
uM
0.00437
0.04204
-0.7526 -0.8693 0.4448 1.2063
0.9147
2.6561
HBL-100
Unknown
Unknown
GSK1070916
AURK
AURK
9226.001
uM
0.70349
3.20790
-0.7877 -1.0000 0.7241 0.4535
0.9635
2.6569
HBL-100
Unknown
Unknown
GSK461364
PLK1
PLK
9226.001
uM
0.11473
5.26970
-0.7351 -1.0000 0.2871 0.4874
0.6569
2.6569
HBL-100
Unknown
Unknown
GSK923295
CENPE
Kinesin
9226.001
uM
0.04394
0.03581
0.1416 0.2409 3.2103 0.4106
0.9796
2.6569
Hs 578T
TNBC
Basal B
Fascaplysin
CDK4
CDK
7474.084
uM
0.83282
1.00080
-0.8699 -0.7532 5.0000 0.4995
0.9908
2.6631
Hs 578T
TNBC
Basal B
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7474.084
uM
474.21380
590.74280
-0.8699 -1.0000 5.0000 0.1198
0.9846
2.6631
Hs 578T
TNBC
Basal B
Methotrexate
DHFR
Metabolism
7474.084
uM
inf
inf
0.8512 0.8512 0.0000 0.0976
0.4506
2.6631
MCF 10A
NM
Basal B
Sirolimus
MTOR
MTOR
7484.068
uM
8.15170
9.87540
0.1105 -0.0202 0.2065 0.3579
0.6480
2.6661
MCF 10A
NM
Basal B
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7483.095
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
2.6732
MCF 10A
NM
Basal B
Ixabepilone
TUBB
TUBB
7483.095
uM
0.0160
0.11519
-0.8965 -0.9405 0.5360 0.8532
0.9476
2.6732
Hs 578T
TNBC
Basal B
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7473.067
uM
7.10170
8.68080
-0.8838 -0.8632 4.9954 0.4373
0.9845
2.6736
Hs 578T
TNBC
Basal B
Ispinesib
KSP
Kinesin
7473.067
uM
0.93986
5.19730
-0.8838 -1.0000 0.6424 0.3695
0.8768
2.6736
Hs 578T
TNBC
Basal B
Purvalanol A
CDK1
CDK
7473.067
uM
inf
inf
0.9516 0.9516 0.0000 -0.0284
-0.2407
2.6736